Market Update: STI returns to 3,000 point level

The Straits Times Index ended Wednesday trading up by 26.50 points or 0.89%, reaching the 3,000.37 point level.

Most Asian stocks also traded in the green, despite the resurgence of US Treasury bonds yields.

About 3.23 billion securities worth S$1.47b changed hands, with advancers outnumbering decliners, 251 to 229.

Top performers for the day were DBS with a 2% or S$0.54 gain, Venture, which rose  by 1.93% or S$0.37, and ComforDelGro which went higher by 1.88% or S$0.03 per share.

On Wall Street, most US stocks traded lower as tech-based shares in particular lagged, and the February private payrolls growth report turned out to be disappointing, indicating that the labor markets there were still struggling.

The S&P 500 shed 1.31% or 50.57 points to end the day at 3,819.72. The NASDAQ also ended lower by 2.70% or 361.03 points dipping to 12,997.75 while the Dow Jones Industrial declined by about 121.43 points or 0.39% to 31,270.09.

London stocks meanwhile, ended flat as investors increased their inflation expectations for the year.

The FTSE 100 ended up by 0.93% or 61.72 points to 6,675.47. The FTSE 250 also went higher by 1.22% or 258.41 points closing at 21,436.32.

Join Singapore Business Review community
Join Singapore Business Review community
A NOTE FROM SINGAPORE BUSINESS REVIEW

Reaching the people who run Asia's businesses is harder than it used to be.

Inboxes are crowded. Attention is short. The executives you most want to reach — the founders, CFOs, and operators who actually move budgets — are the hardest to find through the usual channels. If you're building a company, a category, or a reputation, you already know this.

We've spent twenty years building the room they read. Singapore Business Review is where senior decision makers in Singapore and across Southeast Asia come for business coverage they can't get elsewhere — in print, online, and in person at the summits and roundtables we host across seven markets.

If you have something these readers should know about — a point of view worth publishing, a product worth their attention, an event worth their time — we'd like to hear what you're trying to do.